Ning-Fang Ma Affiliated Cancer Hospital and Institute of Guangzhou Medical University Biography Publications Institution JoVE Articles Ning-Fang Ma has not added a biography. If you are Ning-Fang Ma and would like to personalize this page please email our Author Liaison for assistance. Publications Identification and Functional Characterization of Potential Oncofetal Targets in Human Hepatocellular Carcinoma STAR Protocols. Dec, 2022 | Pubmed ID: 36595904 Correction To: CHD1L Prevents Lipopolysaccharide-induced Hepatocellular Carcinomar Cell Death by Activating HnRNP A2/B1-nmMYLK Axis Cell Death & Disease. Mar, 2022 | Pubmed ID: 35236830 Growth Differentiation Factor 1-induced Tumour Plasticity Provides a Therapeutic Window for Immunotherapy in Hepatocellular Carcinoma Nature Communications. 12, 2021 | Pubmed ID: 34880251 Molecular Subclassification of Gastrointestinal Cancers Based on Cancer Stem Cell Traits Experimental Hematology & Oncology. Nov, 2021 | Pubmed ID: 34774101 CHD1L Augments Autophagy-mediated Migration of Hepatocellular Carcinoma Through Targeting ZKSCAN3 Cell Death & Disease. 10, 2021 | Pubmed ID: 34654797 CHD1L Prevents Lipopolysaccharide-induced Hepatocellular Carcinomar Cell Death by Activating HnRNP A2/B1-nmMYLK Axis Cell Death & Disease. Sep, 2021 | Pubmed ID: 34588420 Diversity Roles of CHD1L in Normal Cell Function and Tumorigenesis Biomarker Research. Mar, 2021 | Pubmed ID: 33663617 Guidelines for the Use and Interpretation of Assays for Monitoring Autophagy (4th Edition) Autophagy. Feb, 2021 | Pubmed ID: 33634751 Targeting Tumor Lineage Plasticity in Hepatocellular Carcinoma Using an Anti-CLDN6 Antibody-drug Conjugate Science Translational Medicine. 02, 2021 | Pubmed ID: 33536280 PARP Inhibitor Olaparib Overcomes Sorafenib Resistance Through Reshaping the Pluripotent Transcriptome in Hepatocellular Carcinoma Molecular Cancer. 01, 2021 | Pubmed ID: 33485358 Identification of Prognostic Claudins Signature in Hepatocellular Carcinoma from a Hepatocyte Differentiation Model Hepatology International. Jul, 2020 | Pubmed ID: 32304089 CHD1L Contributes to Cisplatin Resistance by Upregulating the ABCB1-NF-κB Axis in Human Non-small-cell Lung Cancer Cell Death & Disease. Feb, 2019 | Pubmed ID: 30718500 A Novel Regulatory Axis, CHD1L-MicroRNA 486-Matrix Metalloproteinase 2, Controls Spermatogonial Stem Cell Properties Molecular and Cellular Biology. Feb, 2019 | Pubmed ID: 30455250 CSTF2-Induced Shortening of the 3'UTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder Cancer Research. Oct, 2018 | Pubmed ID: 30143523 Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells Via the C-Myc/microRNA-29b Axis Stem Cells (Dayton, Ohio). Feb, 2018 | Pubmed ID: 29119708 CaMKII-mediated Beclin 1 Phosphorylation Regulates Autophagy That Promotes Degradation of Id and Neuroblastoma Cell Differentiation Nature Communications. Oct, 2017 | Pubmed ID: 29079782 Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids (Video) | JoVE Cheng-Yang Zhang*1,2, Xiao-Feng Zhang*3, Jun Yuan*1,2, Yuan-Feng Gong4, Hui Tang4, Wan-Yu Guo1,2, Tong-Yan Li1,2, Cai-Wen Li1,2, Yun-Qiang Tang4, Ning-Fang Ma1,2, Ming Liu1,2 1Affiliated Cancer Hospital and Institute of Guangzhou Medical University, 2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Center for Cancer Research and Translational Medicine, School of Basic Medical Sciences, Guangzhou Medical University, 3Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, 4Department of Hepatobiliary Surgery, Affiliated Cancer Hospital, Guangzhou Medical University JoVE 65785 Ricerca sul cancro
Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids (Video) | JoVE Cheng-Yang Zhang*1,2, Xiao-Feng Zhang*3, Jun Yuan*1,2, Yuan-Feng Gong4, Hui Tang4, Wan-Yu Guo1,2, Tong-Yan Li1,2, Cai-Wen Li1,2, Yun-Qiang Tang4, Ning-Fang Ma1,2, Ming Liu1,2 1Affiliated Cancer Hospital and Institute of Guangzhou Medical University, 2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Center for Cancer Research and Translational Medicine, School of Basic Medical Sciences, Guangzhou Medical University, 3Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, 4Department of Hepatobiliary Surgery, Affiliated Cancer Hospital, Guangzhou Medical University JoVE 65785 Ricerca sul cancro